AI Scaling in Digital Healthcare and Genomics

Utah's reported acne-care pilot, moving toward AI examination and prescribing without direct human oversight for selected patients, is a notable regulatory and workflow signal. Its narrow scope and staged escalation do not resolve questions about clinical accuracy, patient safeguards, liability, outcomes, or federal authority. Human oversight, external validation, subgroup performance, auditability, and real-world utility remain decisive across healthcare AI.